Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Watson

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
BMC Anesthesiology|October 11, 2014
Current ventilation practice during general anaesthesia: a prospective audit in Melbourne, AustraliaDharshi Karalapillai, Laurence Weinberg, Jonathan Galtieri, et al.
International Journal of Surgery (London, England)|September 7, 2023
Effect of differing flap reconstruction strategies in perineal closure following advanced pelvic oncological resection: a retrospective cohort studyNorman J Galbraith, Catherine McCollum, Lucia Di Mascio, et al.
Journal of Affective Disorders|July 19, 2025
Cost-effectiveness of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression: Economic evaluation of the PAX-BD randomised controlled trialMichael Berger, Timea Helter, Lumbini Azim, et al.
The Lancet Regional Health. Europe|December 3, 2025
Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trialAgata Łaszewska, Timea Helter, Ashley Baldwin, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|December 13, 2023
Ghana 3D Telemedicine International MDT: A proof-of-concept studySteven Lo, Anna Rose, Spencer Fowers, et al.
The Lancet. Psychiatry|January 5, 2016
Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trialR Hamish McAllister-Williams, Ian M Anderson, Andreas Finkelmeyer, et al.
Neuromodulation : Journal of the International Neuromodulation Society|April 10, 2023
The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's SyndromeJessica Tarn, Evelyn Evans, Emmanuella Traianos, et al.
Bjpsych Open|February 15, 2019
Associations between childhood maltreatment and inflammatory markersAlish B Palmos, Stuart Watson, Tom Hughes, et al.
Evidence-Based Mental Health|November 23, 2021
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depressionSheena Kristine Au-Yeung, James Griffiths, Sophie Roberts, et al.
BMC Psychiatry|August 7, 2013
Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)R Hamish McAllister-Williams, Eleanor Smith, Ian M Anderson, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
BMC Anesthesiology|October 11, 2014
Current ventilation practice during general anaesthesia: a prospective audit in Melbourne, AustraliaDharshi Karalapillai, Laurence Weinberg, Jonathan Galtieri, et al.
International Journal of Surgery (London, England)|September 7, 2023
Effect of differing flap reconstruction strategies in perineal closure following advanced pelvic oncological resection: a retrospective cohort studyNorman J Galbraith, Catherine McCollum, Lucia Di Mascio, et al.
Journal of Affective Disorders|July 19, 2025
Cost-effectiveness of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression: Economic evaluation of the PAX-BD randomised controlled trialMichael Berger, Timea Helter, Lumbini Azim, et al.
The Lancet Regional Health. Europe|December 3, 2025
Cost-effectiveness of pramipexole augmentation for acute phase and maintenance therapy of treatment-resistant depression compared to placebo augmentation: economic evaluation of the PAX-D randomised controlled trialAgata Łaszewska, Timea Helter, Ashley Baldwin, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|December 13, 2023
Ghana 3D Telemedicine International MDT: A proof-of-concept studySteven Lo, Anna Rose, Spencer Fowers, et al.
The Lancet. Psychiatry|January 5, 2016
Antidepressant augmentation with metyrapone for treatment-resistant depression (the ADD study): a double-blind, randomised, placebo-controlled trialR Hamish McAllister-Williams, Ian M Anderson, Andreas Finkelmeyer, et al.
Neuromodulation : Journal of the International Neuromodulation Society|April 10, 2023
The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's SyndromeJessica Tarn, Evelyn Evans, Emmanuella Traianos, et al.
Bjpsych Open|February 15, 2019
Associations between childhood maltreatment and inflammatory markersAlish B Palmos, Stuart Watson, Tom Hughes, et al.
Evidence-Based Mental Health|November 23, 2021
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depressionSheena Kristine Au-Yeung, James Griffiths, Sophie Roberts, et al.
BMC Psychiatry|August 7, 2013
Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)R Hamish McAllister-Williams, Eleanor Smith, Ian M Anderson, et al.
Pageof 15